{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:28:42Z","timestamp":1791293322889,"version":"4.1.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001984","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T18:14:26Z","timestamp":1459275266000},"page":"e1001984","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies"],"prefix":"10.1371","volume":"13","author":[{"given":"Maciej F.","family":"Boni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kevin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0163-7258(90)90067-C","article-title":"The prevention of antimalarial drug resistance","volume":"47","author":"W Peters","year":"1990","journal-title":"Pharmac Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in <italic>Plasmodium falciparum<\/italic> malaria","volume":"361","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/infdis\/166.6.1393","article-title":"High-dose mefloquine in the treatment of multi-drug resistant falciparum malaria","volume":"166","author":"FO ter Kuile","year":"1992","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","article-title":"Effects of artesunate-mefloquine combination on incidence of <italic>Plasmodium falciparum<\/italic> malaria and mefloquine resistance in western Thailand: a prospective study","volume":"356","author":"F Nosten","year":"2000","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e4551","DOI":"10.1371\/journal.pone.0004551","article-title":"Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment","volume":"4","author":"VI Carrara","year":"2009","journal-title":"PLoS ONE"},{"key":"ref6","unstructured":"A study by the tracking resistance to artemisinin collaboration (TRACII). 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02453308?term=NCT02453308&rank=1\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02453308?term=NCT02453308&amp;rank=1<\/ext-link>."},{"key":"ref7","author":"R Levins","year":"1968"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0035-9203(86)90248-8","article-title":"A simple model of the build-up of resistance to mixtures of anti-malarial drugs","volume":"80","author":"CF Curtis","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1073\/pnas.94.22.12106","article-title":"Evaluating treatment protocols to prevent antibiotic resistance","volume":"94","author":"S Bonhoeffer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(15)00162-X","article-title":"Optimum population-level use of artemisinin combination therapies: a modelling study","volume":"3","author":"TD Nguyen","year":"2015","journal-title":"Lancet Glob Health"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.0804628105","article-title":"Benefits of using multiple first-line therapies against malaria","volume":"105","author":"MF Boni","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-9-217","article-title":"Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty","volume":"9","author":"DL Smith","year":"2010","journal-title":"Malar J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/1475-2875-11-422","article-title":"Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach","volume":"11","author":"T Antao","year":"2012","journal-title":"Malar J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0031182011001144","article-title":"Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric cases?","volume":"138","author":"CJ Sutherland","year":"2011","journal-title":"Parasitology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(09)61767-0","article-title":"Cost is killing patients: subsidising effective antimalarials","volume":"374","author":"A Talisuna","year":"2009","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e6857","DOI":"10.1371\/journal.pone.0006857","article-title":"Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania","volume":"4","author":"OJ Sabot","year":"2009","journal-title":"PLoS ONE"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12936-015-0787-z","article-title":"Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015)","volume":"14","year":"2015","journal-title":"Malar J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jiq001","article-title":"Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of <italic>Plasmodium falciparum<\/italic> infection in Guinea-Bissau: a randomized trial","volume":"203","author":"J Ursing","year":"2011","journal-title":"J Infect Dis"},{"key":"ref19","article-title":"Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial","author":"A Yeka","year":"2015","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jeem.2000.1156","article-title":"Economics of Antibiotic Resistance: A Theory of Optimal Use","volume":"42","author":"R Laxminarayan","year":"2001","journal-title":"J Env Econ Manag"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:53:49Z","timestamp":1588971229000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001984","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}